financetom
Business
financetom
/
Business
/
NeoTerrex Minerals Up 5% On Gold, Copper and Tungsten Assay Results for Its Gravitas Project in Quebec
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NeoTerrex Minerals Up 5% On Gold, Copper and Tungsten Assay Results for Its Gravitas Project in Quebec
Oct 28, 2025 10:48 AM

01:22 PM EDT, 10/28/2025 (MT Newswires) -- NeoTerrex Minerals ( NTXMF ) shares rose 5% on Tuesday after it reported additional assays from its summer exploration program at its Gravitas project in Abitibi-Temiscamingue, Quebec.

The company said grab samples from the northern block were extracted from exposed quartz veins with four grab samples assaying between 0.1% to 0.5% Petosa Tungsten. Additional mineralized quartz veining was discovered 500-meters south of the Petosa zone.

Three grab samples returned copper (Cu) values between 1.16% and 1.23%, and eight grab samples assayed between 0.11 grams per tonne (g/t) gold and 0.61 g/t of gold.

The company's exploration team was able to extend the previously reported north-south trending quartz vein hosting copper-bearing sulfides of 25-meter strike length from its southern block, by 10 meters with grab samples assaying 1.80% and 4.06% Cu and with silver values of 9.09 g/t and 13.3 g/t of gold in grab samples.

Shares of the company were last seen up $0.015 to $0.31 on the TSX Venture Exchange.

Price: 0.31, Change: +0.02, Percent Change: +5.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aethlon Medical Receives Ethics Approval for Hemopurifier Cancer Trial in India
Aethlon Medical Receives Ethics Approval for Hemopurifier Cancer Trial in India
Sep 22, 2024
08:49 AM EDT, 09/19/2024 (MT Newswires) -- Aethlon Medical ( AEMD ) said Thursday that the Medanta Institutional Ethics Committee has granted full ethics approval for its clinical trial of the Hemopurifier in cancer patients undergoing anti-PD-1 therapy. The approval is valid for one year, followed by annual reviews. The trial, which received a no objection certificate from Indian regulators,...
Coeptis Therapeutics Receives Nasdaq Listing Extension
Coeptis Therapeutics Receives Nasdaq Listing Extension
Sep 22, 2024
08:48 AM EDT, 09/19/2024 (MT Newswires) -- Coeptis Therapeutics ( COEP ) said Thursday that it received approval from the Nasdaq Hearings Panel to remain listed on Nasdaq through Jan. 15, 2025. The company was granted a Nasdaq listing extension after presenting a plan, including a reverse stock split, to address the minimum bid price requirement. Nasdaq issued a notice...
Arqit Quantum to Implement 1-for-25 Reverse Share Split
Arqit Quantum to Implement 1-for-25 Reverse Share Split
Sep 22, 2024
08:47 AM EDT, 09/19/2024 (MT Newswires) -- Arqit Quantum ( ARQQ ) said Thursday its board approved a 1-for-25 reverse share split. The company's stock will begin trading on a split-adjusted basis on Nasdaq from Sept. 25, Arqit Quantum ( ARQQ ) said. The provider of cybersecurity services said it expects to regain compliance with Nasdaq's minimum bid price requirement...
Cadiz Appoints Cathryn Rivera as Chief Operating Officer
Cadiz Appoints Cathryn Rivera as Chief Operating Officer
Sep 22, 2024
09:03 AM EDT, 09/19/2024 (MT Newswires) -- Cadiz (CDZI) said Thursday it appointed Cathryn Rivera as chief operating officer, effective Sept. 16. Before joining the company, Rivera served as appointments secretary for California Governor Gavin Newsom from 2019 to 2024, Cadiz said. Price: 3.2500, Change: +0.04, Percent Change: +1.25 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved